Clinical trial
Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced…
NCT00459043 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00459043 |
|---|---|
| Title | Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck |
| Official title | Randomized Phase II Study of Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital Loyola University AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma of Head and Neck |
| Intervention type | Drug |
| Interventions | ZD6474, Docetaxel |
| Enrollment | 30 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Feb 1, 2012 |
| First posted | Apr 11, 2007 |
| Last update posted | Jul 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: